These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8075778)

  • 1. Reversed-phase high-performance liquid chromatographic database of retention indices and UV spectra of toxicologically relevant substances and its interlaboratory use.
    Bogusz M; Erkens M
    J Chromatogr A; 1994 Jul; 674(1-2):97-126. PubMed ID: 8075778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardized HPLC/DAD system, based on retention indices and spectral library, applicable for systematic toxicological screening.
    Bogusz M; Wu M
    J Anal Toxicol; 1991; 15(4):188-97. PubMed ID: 1943068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of an HPLC-DAD drug-screening system based on retention indices and UV spectra.
    Elliott SP; Hale KA
    J Anal Toxicol; 1998; 22(4):279-89. PubMed ID: 9681330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic toxicological analysis by high-performance liquid chromatography with diode array detection (HPLC-DAD).
    Pragst F; Herzler M; Erxleben BT
    Clin Chem Lab Med; 2004; 42(11):1325-40. PubMed ID: 15576293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a high-performance liquid chromatography retention index scale for toxicological drug screening.
    Elliott SP; Hale KA
    J Chromatogr B Biomed Sci Appl; 1997 Jun; 694(1):99-114. PubMed ID: 9234853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of biological matrix on chromatographic behavior and detection of selected acidic, neutral, and basic drugs examined by means of a standardized HPLC-DAD system.
    Bogusz M; Erkens M
    J Anal Toxicol; 1995; 19(1):49-55. PubMed ID: 7723302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selectivity of substance identification by HPLC-DAD in toxicological analysis using a UV spectra library of 2682 compounds.
    Herzler M; Herre S; Pragst F
    J Anal Toxicol; 2003; 27(4):233-42. PubMed ID: 12820746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved standardization in reversed-phase high-performance liquid chromatography using 1-nitroalkanes as a retention index scale.
    Bogusz M; Aderjan R
    J Chromatogr; 1988 Jan; 435(1):43-53. PubMed ID: 3350897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification power of a standardized HPLC-DAD system for systematic toxicological analysis.
    Maier RD; Bogusz M
    J Anal Toxicol; 1995; 19(2):79-83. PubMed ID: 7769791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An automated screening method for drugs and toxic compounds in human serum and urine using liquid chromatography-tandem mass spectrometry.
    Sturm S; Hammann F; Drewe J; Maurer HH; Scholer A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(28):2726-32. PubMed ID: 20846915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicological screening of drugs by microbore high-performance liquid chromatography with photodiode-array detection and ultraviolet spectral library searches.
    Turcant A; Premel-Cabic A; Cailleux A; Allain P
    Clin Chem; 1991 Jul; 37(7):1210-5. PubMed ID: 1855291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A reassessment of 'use of corrected retention indices based on 1-nitroalkane and alkylarylketone scales for HPLC identification of basic drugs'.
    Smith RM; Gill R; Osselton MD
    J Anal Toxicol; 1989; 13(6):375-7. PubMed ID: 2607768
    [No Abstract]   [Full Text] [Related]  

  • 13. HPLC-DAD for analysis of different classes of drugs in plasma.
    Alabdalla MA
    J Clin Forensic Med; 2005 Dec; 12(6):310-5. PubMed ID: 16084748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of foscarnet (trisodium phosphonoformate) in pharmaceutical preparations by high-performance liquid chromatography with ultraviolet detection.
    García J; Márquez A; Ruiz R; López LF; Claro C; Lucero MJ
    Biomed Chromatogr; 2006 Oct; 20(10):1024-7. PubMed ID: 16583452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer assisted substance identification in systematic toxicological analysis: New life for old methods?
    Linden R; Feltraco LL; Comerlato LC; Kellermann E; Antunes MV
    Forensic Sci Int; 2010 Oct; 202(1-3):e53-60. PubMed ID: 20554409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indirect spectrophotometric detection by reversed-phase liquid chromatography. Application in drug analysis].
    Herne P
    J Pharm Belg; 1990; 45(2):151-9. PubMed ID: 2192023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversed-phase solvent-gradient HPLC retention indexes of drugs.
    Hill DW; Kind AJ
    J Anal Toxicol; 1994 Sep; 18(5):233-42. PubMed ID: 7990438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of linezolid in human serum by reversed-phase high-performance liquid chromatography with ultraviolet and diode array detection.
    Cios A; Kuś K; Szymura-Oleksiak J
    Acta Pol Pharm; 2013; 70(4):631-41. PubMed ID: 23923387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic toxicological analysis of basic drugs by gradient elution of an alumina-based HPLC packing material under alkaline conditions.
    Lambert WE; Meyer E; De Leenheer AP
    J Anal Toxicol; 1995; 19(2):73-8. PubMed ID: 7769790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gas-liquid chromatographic retention indices of 1318 substances of toxicological interest on SE-30 or OV-1 stationary phase.
    Ardrey RE; Moffat AC
    J Chromatogr; 1981 Dec; 220(3):195-252. PubMed ID: 7035473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.